Documentation Requirements for Home Visits in Decentralized Clinical Trials
Home visits lack direct oversight from study coordinators or investigators. Therefore, documentation must:
Click to read the full article.
Decentralized Clinical Trials (DCTs)
Logistics for Sample Collection and Shipment from Homes in Decentralized Clinical Trials
Unlike centralized site visits, home sample collection must account for environmental variables, geographic dispersion, and lack of immediate lab access. Failure to manage logistics effectively can result in:
Click to read the full article.
Adapting SOPs for Decentralized Study Procedures in Clinical Trials
DCTs bring unique operational shifts that can’t be managed under legacy SOPs designed for site-based models. Key drivers for SOP revision include:
Click to read the full article.
When to Choose Home Health Over Site Visits in Decentralized Clinical Trials
The traditional site visit model can introduce logistical, financial, and emotional burdens for participants. Home health visits offer:
Click to read the full article.
Real-World Examples of Successful Home Health Visit Implementation in Clinical Trials
While theoretical guidance and SOPs are critical, understanding how leading sponsors operationalize DCTs helps bridge the gap between design and execution. These examples illustrate:
Click to read the full article.
Designing Protocols for Direct-to-Patient (DTP) Drug Delivery in Decentralized Clinical Trials
As clinical trials move away from site-centric designs, the need for reliable, compliant home delivery systems has grown. DTP models enable:
Click to read the full article.
Real-World Implementation of eConsent in Global Clinical Trials
Traditional paper-based consent methods are no longer viable in the decentralized era. Sponsors must:
Click to read the full article.
Security Standards for Storing Digital Consent in Clinical Trials
Digital informed consent forms (ICFs) contain personally identifiable information (PII) and sometimes protected health information (PHI). Breaches in storage security can lead to:
Click to read the full article.
Patient Feedback Mechanisms in eConsent Tools for Clinical Trials
Patient-centricity in clinical trials is no longer optional. Feedback from trial participants can uncover pain points, enhance understanding, and identify improvements. Specific benefits of integrating feedback into eConsent platforms include:
Click to read the full article.
Re-Consent and Version Tracking Using eConsent in Clinical Trials
Re-consent refers to obtaining participants’ renewed consent when significant changes occur after initial enrollment, such as:
Click to read the full article.